Canadian Pharmacovigilance and Risk Management Conference

Back to Agenda

Session 2: Round Table with Inspector

Session Chair(s)

Rita Cassola, RPh

Executive Director PV

Certus PV Services Inc, Canada

In this session, a representative from the Good Pharmacovigilance Practices (GVP) Inspection Program of Health Canada will discuss updates of the Program. The session will discuss:

Inspection trends observed during fiscal year 2019-2020
The addition of market authorization holders located outside of Canada within the scope of the Program
The impact of COVID-19 on GVP inspections and other upcoming elements of the GVP Program Review
Other on-going initiatives within the Program

Learning Objective : At the conclusion of this session, participants should be able to:
Understand the recent updates to the GVP Inspection Program in Canada
Identify what inspection findings were found in recent Health Canada GVP inspections
Understand what is expected during Health Canada GVP inspections

Speaker(s)

Updates on the Good Pharmacovigilance Practices (GVP) Inspection Program

Marc-André Giguère

Health Canada, Canada

Senior Policy Analyst

Have an account?